Lithium succinate

Lithium succinate

Clinical data
Other names	Lithium succinate dibasic
AHFS/Drugs.com	Monograph
ATC code	D11AX04 ( WHO )
Identifiers
IUPAC name Dilithium butanedioate
CAS Number	29126-50-9
PubChem CID	10197702
DrugBank	DB14508  Y
ChemSpider	8373202  Y
UNII	MD64P82Y28
ChEMBL	ChEMBL3707288
ECHA InfoCard	100.163.153
Chemical and physical data
Formula	C4H4Li2O4
Molar mass	129.95 g·mol−1
3D model (JSmol)	Interactive image
SMILES [Li+].[Li+].[O-]C(=O)CCC([O-])=O
InChI InChI=1S/C4H6O4.2Li/c5-3(6)1-2-4(7)8;;/h1-2H2,(H,5,6)(H,7,8);;/q;2*+1/p-2 Y Key:WAHQBNXSPALNEA-UHFFFAOYSA-L Y
(verify)

Lithium succinate (C₄H₄Li₂O₄), the dilithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis ^[1] and proposed for the treatment of anogenital warts. ^[2]

References

1. Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology. 187 (2): 149–50. doi:10.1159/000247228. PMID   8358107.
2. Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International Journal of STD & AIDS. 8 (8): 515–7. doi:10.1258/0956462971920677. PMID   9259500. S2CID   23095115.

External links

• "Lithium succinate". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on November 4, 2022.